Adaptation and Beta Testing of an Online Group Intervention for Family Caregivers of Children with Rare Diseases
Background: Family caregivers of children with rare diseases are more likely to have symptoms of anxiety, depression, and post-traumatic stress disorder (PTSD). The WHO’s Group Problem Management Plus (Group PM+) is an evidence-based intervention providing psychological help for adults impaired by distress while exposed to adversity. Our objective was to adapt and beta test Group PM+ with family caregivers. Methods: Family caregivers were >18.0 years at enrollment experiencing psychological distress. Rare Group PM+ is five weekly sessions teaching stress management, problem solving, and building social support. Assessments were the PTSD Checklist for DSM-5 (PCL-5), Patient Health Questionnaire-9, and Generalized Anxiety Disorder-7. Paired Wilcoxon signed-rank tests measured the median baseline and 2-week follow-up values. Results: Sessions were reduced to 90 min and delivered through telehealth. Eight participants enrolled, including seven females with mean age of 40 years. Completion and retention rate were 100% (8/8). Participant-identified barriers to joining included: time constraints; concerns about re-traumatization; and confidentiality. PCL-5 decreased from a median of 29 to 17.5; GAD-7 from 11.5 to 4.5; and PHQ-9 median scores decreased but not significantly. Conclusions: Rare Group PM+ demonstrated initial acceptability and feasibility. Future research should examine initial efficacy in a larger rigorous pilot randomized controlled clinical trial.
Authors
- Thevaa Chandereng (ORCID: https://orcid.org/0000-0003-4078-9176)
- Abdulla Ali (ORCID: https://orcid.org/0000-0003-2408-6147)
- Maureen E. Lyon (ORCID: https://orcid.org/0000-0002-0955-3969)
- Debra S. Regier (ORCID: https://orcid.org/0000-0001-7525-0088)
- Danielle Schwalk (ORCID: https://orcid.org/0009-0005-5084-5882)
Institutions
- Children's National (US)
- George Washington University (US)
- Levine Children's Hospital (US)
Publication Details
- Journal
- Disabilities
- Published
- 2026-08-14
- DOI
- https://doi.org/10.3390/disabilities6040071
- Primary Topic
- Childhood Cancer Survivors' Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Travere Therapeutics